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Summary.-A recently introduced assay of cell mediated immunity and humoral
inhibitory factors has been evaluated in colorectal cancer patients. Using a per-
chloric acid extractofadenocarcinoma ofthelargebowel as antigen, 16/27patientswith
colorectal cancer had significant cellular reactivity when their separated peripheral
leucocytes were tested in homologous AB serum. In autologous serum only7/27 had
significant reactivity; 6/20 patients with a variety of other malignancies showed
sensitization to the colorectal antigen preparation.
It is concluded that the leucocyte adherence inhibition test may offer a simple
method of assaying for serum blocking factors in sequential studies but will be of
little value in the diagnosis of large bowel cancer.
In vitro techniques for assessing im- human malignancies (Maluish anld Halli-
munological reactivity have facilitated day, 1974).
the study of the immune response to The principle of the test is that when
human cancer and of factors which specifically sensitized lvmphocytes are
modify its expression. Such information incubated with the antigens, a lymphokine
is of much more than theoretical impor- is released which decreases the normal
tance as it could provide guidelines for tendency of leuocytes to adhere to a
planning suitable immunotherapy ormoni- glass surface. This is analogous to the
toring the post-operative clinical course of macrophage migration system in which a
patients. product ofantigen lymphocyte interaction
Lymphocyte cytotoxicity (Hellstr0m causes inhibition ofmacrophage migration.
et al., 1971a), lymphocyte transformation To date the LAI test has been used
(Vanky et al., 1971) and leucocyte migra- only to investigate small groups of
tion inhibition techniquLes (Anderson et al., patients with a specific cancer. The
1970; Guillou and Giles, 1973) have been present study was an attempt to evaluate
used to show specific cell mediated im- this potentially useful test in a group of
munity to tumour associated antigens in a 27 patients with colorectal cancer.
variety of human malignancies. These
tests are, however, time consuming, may
require complex equipment and are often PATIENTS AND METHO1)S
difficult to interpret. Twenty-seven patients (mean age 656
Recently, the leucocyte adherence years) with primary adenocarcinoma of the
inhibition (LAI) test has been described bv large bowel were studied pre-operatively.
Halliday, Maluish and Isbister (1974) a,These were compared with 19 control Halliday,Maluish and .sbister( as subjects (12 healthy volunteers and 7 patients both a simple and rapid in vitro test of with benign disease, mean age 57-1 years) and
cellular reactivity in human cancer. The 20 patients (mean age 68-2 years) with
test was first used for experimental various other malignancies.
murinie tumours (Halliday, Maluish anid A perchloric acid extract of surgically
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prepared after the method of Freed and American Corporation). After a further
Taylor (1972). None ofthe tumours used for 60 min incubation, the nucleated cells in a
this extract were autochthonous with respect predetermined pattern ofsquares (16 squares/
to the patients studied. The tumour extract haemacytometer) were counted. The cover-
was sterile on culture and furthermore an slips were then floated offand slides subjected
antiserum raised against the extract failed to to a gentle washing procedure; the remaining,
agglutinate the common enteric bacteria. adherent cells were then counted in the same
As used in the LAI test this extract contained squares.
10 pg protein/ml (Kjeldahl). The mean percentage adherence for each
The technique of the LAI test was mixture was determined and a leucocyte
essentially as originally described (Halliday adherence index calculated.
et al., 1974a). Leucocytes were obtained by Leucocyte adherence index
sedimentation for 1 h at 370C from heparin-
ized blood, any remaining red cells being Mean % adherence with antigen
lysed by brief treatment with 0 15mol/I - Mean % without antigen
ammonium chloride. After washing, the
leucocytes were finally resuspended to a RESULTS
concentration of 2 x 107/ml in tissue culture The mean percentage adherence for medium 199 (Wellcome) with 10% foetal calf each mixture and the leucocyte adherence
serum added.
Equal volumes (0.05 ml) of the leucocyte indices for tle control subjects, colorectal
suspension, tumour extract (when required) and other malignancies are shown in
and undiluted pooled AB or autologous serum Tables I, II and III respectively.
were mixed with TC 199 + 10% foetal calf The control subjects exhibited little or
serum, to give a final volume of0-2 ml. Each no reduced adherence in the presence of
ofthe mixtures was set up in duplicate. The the tumour extract either in homologous
tubes were randomized, coded and then ABserum (mean index 1 024 1 0-0547 s.d.)
incubated at 37°C for 30 min with constant or autologous serum (mean index 1-0421
mixing. In view ofthe short incubation time or0autologous s (mean nd 1igni- in this assay, antibiotics were not added to ±icant d.). Asthee was noasgni the culture medium. ficant difference between the healthy
Leucocyte adherence was then deter- subjects and the patients with benign
mined by introducing each mixture into the disease, they have been treated as one
2 chambers of a haemacytometer (Optical group. No nonspecific or toxic effects of
TABLE I.-Results ofLAI Test in Control Patients
Mean % adherence Leucocyte adherence
Patients index
-_______________________ _ -A AB AB serum Auto serum
Age Sex Diagnosis serum +antigen +antigen AB Auto
30 M Healthy 53 49 47 O 92 0 9
61 M Healthy 73 74 71 1-01 0 98
49 M Healthy 57 64 63 1-12 1-1
69 M Healthy 62 66 57 1-06 0 -92
74 M Healthy 46.5 47 54 1 01 1-16
45 F Healthy 59 60 72 1-02 1 22
52 M Healthy 75 71 79 O 95 1-05
53 F Healthy 67-5 70 5 71-5 1-04 1 06
58 F Healthy 70 71 67 1-01 0 96
61 F Healthy 65-5 63 -5 69 0 97 1-05
55 F Healthy 71-5 71-3 76 0 99 1 06
59 F Healthy 63 61 69 0 97 1-09
75 M Urethral stricture 44 48 50 1-09 1-13
40 M Spontaneous pneumothorax 69 71 67 1-03 0 97
71 M Angina 56 64 57 1-14 1-07
45 M Gastric ulcer 57 60 52 1-05 0-91
66 M Diverticulitis 51 55 52 1-07 1-02
72 M Osteoarthritis 59 58 68 1 -02 1 - 15
50 M Fissure-in-Ano 73 72-5 73 0- 99 1.0570 P. R. ARMITSTEAD AND G. GOWLAND
TABLE II.-Results of LAI Test in Patients with Colorectal Cancer
Mean % adherence
Patients A
, Leucocyte adherence index
A - - & o AB AB serum Auto serum._ _ _ _
Age Sex Diagnosis Stage* serum +antigen +antigen AB Auto
45 F Ca colon D 73*5 36 31 0 49 0 43
52 M Ca colon D 62 69 65 1-1 1-03
68 F Ca colon D 58 74 43 1-27 0 74
76 M Ca rectum D 79 70 59 0 85 0 75
69 M Ca rectum D 46 48 67 1-04 1-45
67 M Ca rectum C 72 50 30 0 69 0-41
80 F Ca colon C 62 50 78 0 8 1-26
65 M Ca colon C 58 49 49 0-84 0 84
58 F Ca colon D 66 57 84 0 86 1P26
49 M Ca rectum C 69 54 72 0 78 1 05
69 M Ca rectum D 87 64 84 0 74 0 97
78 M Carectum C 75 74 84 0.99 1-12
53 F Ca colon D 80 77 81 0-96 1-01
70 M Ca colon A 55 58 57 1.05 1-03
68 F Ca colon C 57 42 60 0 74 1.05
77 F Ca rectum B 66 55 77 0 83 1-16
65 M Ca rectum D 48 42 38 0 87 0 81
73 M Ca rectum D 67 62 79 0 93 1-17
53 M Ca colon B 68 59 64 0 87 0 94
79 P1' Ca rectum A 41 44 44 1-07 1-07
67 M Ca colon B 70 77 67 1 1 0 96
54 M Ca colon D 64 54 65 0 78 1901
67 M Ca colon D 53 41 43 0 76 0-81
71 F Cacolon C 52 55 62 1-05 1-19
68 F Ca colon D 83 73 84 0 88 1-02
62 F Ca rectum A 50 48 67 0-97 1-3
69 M Ca rectum B 69 56 65 0-81 0 94
* A = Confined to bowel.
B = Invading para-colonic tissues, nodes -ve.
C = Involvement of lymph nodes.
D = Distant metastases.
TABLE III.-Results ofLAI Test in Patients with Other Malignancies
Mean % adherence
Patients ,_ _ _Leucocyte adherence index
_____________________________ -AB AB serum Auto serum A_ _
Age Sex Diagnosis Stage* serum +antigen +antigen AB Auto
66 M Seminoma L 72 68 65 1-07 1.05
75 F Cabreast M 71-5 59 83 0 8 191
62 F Ca thyroid M 49 47 64 0-96 1-3
57 M Ca lung M 86 64 51 0 74 0.59
58 F Rectal melanoma M 83 75 88 0 90 1 06
55 F Ca breast M 89 85 88 0-96 0.99
63 M Ca lung L 86 85 91 0.99 1-06
67 M Ca lung L 52 51 55 0*99 1-06
75 M Ca oesophagus M 52 52 59 1.0 1-13
83 M Ca stomach M 88 81 80 0*92 0-91
69 F Ca stomach M 77 76 79 0.99 1-03
74 F Ca cervix L 62-5 66 76 1-05 1-2
73 M Ca prostate M 77 77-5 81 1.0 1.05
73 F Ca stomach M 81 68 74 0-83 0-91
74 F Anal melanoma M 69 58 43 0-83 0-63
67 F Ca biliary tract M 73 57 45 0 8 0-61
75 F Ca stomach M 65 70 60 1-07 0-92
81 F Ovarian ca M 78-5 79 77-5 1-00 0.99
73 F Ca breast L 82 79 83 0 96 1.01
73 M Ca bladder L 68 65 78 0-96 1.15
* L = Localized; M = Metastatic.LEUCOCYTE ADHERENCE INHIBITION TEST IN CANCER OF LARGE BOWEL 571
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the tumour extract were apparent in any serum. The patients showing the sensiti-
of these tests. zation in this group had metastatic cancer
Therefore, in this study, significantly Of the breast, lung, stomach, rectal
reduced leucocyte adherence in the pres- melanoma (2) or biliary tracts. Patients
ence ofthe tumour extract is said to have without metastases were uniformly n-ega-
occurred when the index falls below the tive.
95%/ confidence limits (mean -2 s.d.)
DSUSO
calculated from all the control subject Dsuso
observations. The results obtained in AB This study has confirmed that the
serum are shown in Fig. 0 and those in interaction between human leucocytes
autologous serum in Fig. 2. from patients with colorectal cancer and
In the patients with colorectal cancer an extract of pooled colorectal tumours
of all stages 16/27 (59-25%) showed a sig- causes a reduced adherence of the cells to
nificantly reduced index in homologous a glass surface. This reduced adherence
AB serum, whereas in autologous serum does not appear to be due to toxicity of
only7(26%) showed asignificantlyreduced the tumour extract since adherence of the
index. Of the 20 patients with other control subjects' leucocytes was not
malignancies, 6 (30%/) showed a signi- affected. Similarly, as 4 multiparous
ficantly reduced index in homologous AB female control subjects showed no reduced
serum and 3 (15%) in their autologous adherence, presensitization to alloantigens572 P. R. ARMITSTEAD AND G. GOWLAND
seems unlikely. As the assay mixtures (Maluish and Halliday, 1974). In our
were incubated only for a short time, in experience the tedious visual cell counting
vitro sensitization by histocompatibility and technical dexterity necessary for
antigens possibly present in the extracts consistent results might limit its useful-
can be excluded. ness. The modification of the test by a
Unfortunately the LAI test as per- radioisotope technique, recently described
formed here appears to be of little use in by Peirce and Devald (1974) in animals,
the positive diagnosis of large bowel could overcome these difficulties if suc-
cancer since only 16 of the 27 patients cessfully applied to man.
studied exhibited significant reactivity to In this study the tumour antigen prep-
the colorectal tumour extract. A different aration was extracted with perchloric
type of extract may increase the sensi- acid, an established method for preparing
tivity but it is of interest that similar carcinoembryonic antigen (CEA). Indeed,
proportions of patients are reported to our extract has been shown to contain
show sensitization to tumour associated CEA, among other antigens, by the use of
antigens in large bowel malignancy and heterologous antiserum and a purified
other cancers by the leucocyte migration CEA preparation (Medical Research
technique (Andersen et al., 1970; Guillou Council, CEA C73/601). The adherence
and Giles, 1973). inhibition was specific for patients with
No difference in reactivity in homo- tumours but not organ specific. The
logous AB serum was seen between other carcinomata which were reactive
patients whose tumours were locally con- were of types which can produce elevated
fined (Dukes Stage A, B and C) and those serum CEA levels (Pusztaszeri and Mach,
with distant spread (Stage D). This 1972). It is of interest to speculate on its
clinical-pathological staging, although immunogenic role, although Lejlenyi,
useful, probably does not truly represent Freedman and Gold (1971) found no
the natural history of the disease. How- evidence for a cell mediated immune
ever, 4/4 with histologically de-differen- reaction to purified CEA using a lympho-
tiated tumours showed reactivity, 6/11 cyte transformation technique. Hell-
with moderately differentiated tumours strom, Hellstrom and Shepard (1970)
and 6/12 with well differentiated growths. demonstrated that lymphocytes from
A humoral inhibitory effect of auto- patients with carcinoma of the colon,
logous sera was present in 10/16 patients which reacted specifically with colon
who showed reactivity when tested in cancer cells in vitro, were also cytotoxic
homologous AB serum. This is analogous to foetal gut and liver epithelial cells;
to the serum blocking factors reported also, a delayed skin reaction to extracts of
using the lymphocyte cytotoxicity tech- foetal human gut tissue containing CEA
niques (Hellstrom et al., 1971b) and might was found in patients with carcinoma of
represent one means by which the cellular the colon and rectum (Hollinshead et al.,
immunological effects of sensitized leuco- 1970), however purified CEA elicited no
cytes might be inhibited in vivo in the skin reaction in the one patient tested.
cancer patient. In our opinion, it is as an The relationship between embryonic
assay for serum blocking that the LAI macromolecules found in tumour tissue
test has its greatest potential use, par- and antigens involved in anti-tumour
ticularly in sequential studies of post- immunity still remain to be resolved.
excision patients, as the appearance of
blocking factors is reported to herald We thank the surgeons of Leeds (St
recurrent growth. James's) University Hospital for allowing
The LAI test is claimed to be a rapid us to study patients under their care and
and simple in vitro method of detecting also the Medical Research Council for
sensitization to tumour associatedantigens their gift of CEA.LEUCOCYTE ADHERENCE INHIBITION TEST IN CANCER OF LARGE BOWEL 573
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